# Prevalence and risk factors of deep vein thrombosis in elderly: a systematic review and meta-analysis

**Authors:** Yajie Ren, Runbing Liu

PMC · DOI: 10.1515/med-2025-1333 · Open Medicine · 2026-01-21

## TL;DR

This study reviews how common deep vein thrombosis is in elderly people and identifies key risk factors like age, cancer, recent surgery, and elevated D-dimer levels.

## Contribution

The study provides a meta-analysis of DVT prevalence and risk factors in elderly populations across multiple countries.

## Key findings

- Overall DVT prevalence in elderly is 17.10%.
- Malignancy and recent surgery significantly increase DVT risk.
- Elevated D-dimer levels are strongly linked to DVT.

## Abstract

Deep vein thrombosis (DVT) demonstrated significant health risk in elderly populations, with numerous comorbidities and biomarkers affecting its incidence. This study evaluated the prevalence, potential allied risk factors for DVT in elderly.

A literature search was conducted across PubMed, Science Direct, Cochrane Library, and Google Scholar. After excluding studies, 26 studies were comprised in the study. Data were collected for DVT prevalence and associated risk factors.

A total of 11,651 participants comprised from China, Japan, Germany, Saudi Arabia, and Thailand. The overall DVT prevalence was 17.10 %, with higher prevalence in females (67.08 %) than males (32.92 %). Age was significantly associated with increased DVT risk (OR=1.54, 95 % CI: 0.34–2.73, p<0.01). While DVT incidence was insignificantly higher among hypertensive and diabetic patients. Significant associations identified between DVT occurrence and malignancy (OR=1.36, 95 % CI: 1.02–1.83, p<0.04), as well as recent surgical history (OR=1.34, 95 % CI: 1.01–1.77, p<0.04). Elevated D-dimer were strongly linked to DVT risk (OR=1.13, 95 % CI: 1.08–1.17, p<0.001).

This review suggested the significant impact of aging, malignancy, recent surgery, and elevated D-dimer levels on DVT risk in elderly and recommends the assessment of clinical signs, risk factors, and biomarkers in elderly individuals.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), malignancy (MONDO:0004992)

## Full-text entities

- **Genes:** F5 (coagulation factor V) [NCBI Gene 2153] {aka FVL, PCCF, RPRGL1, THPH2, fV}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, SELP (selectin P) [NCBI Gene 6403] {aka CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM}, PTAFR (platelet activating factor receptor) [NCBI Gene 5724] {aka PAFR}
- **Diseases:** cellulitis (MESH:D002481), heart failure (MESH:D006333), fatigue (MESH:D005221), stroke (MESH:D020521), inherited thrombophilias (MESH:C540694), MS (MESH:D009103), metabolic abnormalities (MESH:D008659), pulmonary embolism (MESH:D011655), venous stasis (MESH:D054070), trauma (MESH:D014947), chronic inflammation (MESH:D007249), thrombotic (MESH:D013927), Hypertension (MESH:D006973), leg pain (MESH:D010146), fracture (MESH:D050723), VTE (MESH:D054556), chronic venous insufficiency (MESH:D014689), coagulation (MESH:D001778), cardiovascular disease (MESH:D002318), diabetes (MESH:D003920), lymphedema (MESH:D008209), Malignancies (MESH:D009369), vascular injury (MESH:D057772), vascular dysfunction (MESH:D002561), DVT (MESH:D020246), leg swelling (MESH:D004487), chronic kidney disease (MESH:D051436)
- **Chemicals:** D (MESH:D003903)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917581/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917581/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917581/full.md

---
Source: https://tomesphere.com/paper/PMC12917581